GPC vs IMRX · P/E 21, rev $23.49B vs $124.2M cap
Genuine Parts Co (GPC) versus Immuneering Corp (IMRX) — a side-by-side from cached financials, not a winner call.
Genuine Parts Co (GPC) is a auto parts company listed on US.
Immuneering Corp (IMRX) is a biotechnology company listed on US.
Latest reported GPC revenue for 2024-12-31 was $23.49B. Net income was $904.1M. Revenue was up 1.7% from 2023-12-31 to 2024-12-31. GPC currently screens at market cap $17.60B and trailing P/E 20.7.
Latest reported IMRX revenue for 2023-12-31 was $0. Net income was -$53.5M. Revenue was down 100.0% from 2022-12-31 to 2023-12-31. IMRX currently screens at market cap $124.2M.
GPC currently screens at market cap $17.60B and trailing P/E 20.7. IMRX currently screens at market cap $124.2M.
Not investment advice. Open the GPC and IMRX stock pages for the full models.
Not investment advice.